Resources Contact Us Home
Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof

Image Number 5 for United States Patent #8101721.

The present invention is related to antibodies with binding affinity to fibroblast growth factor receptor 2 (FGFR2) optionally with binding affinity to other FGF receptors, which block both ligand-dependent and constitutive ligand independent receptor activation. Specifically, the present invention relates to antibodies with high affinity to more than one FGF receptor subtype, and fragments thereof, useful in treating disorders including cell proliferative diseases.

  Recently Added Patents
Node and wireless sensor network comprising the node
Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-d- ione structural scaffold, their biological activity, and uses thereof
Backlight assembly, method for driving backlight assembly, and liquid crystal display having the same
Contact lens material
Implant free extremely thin semiconductor devices
O-space imaging: highly efficient parallel imaging using complementary nonlinear encoding gradient fields and receive coil geometries
Communicating channel state information using predictive vector quantization
  Randomly Featured Patents
Array substrate for in-plane switching liquid crystal display device and method of fabricating the same
Systems and methods for analyzing network traffic
Method of directive transmission and directivity-controlled communication device
Material mixing container
Housing for electrical connectors
Cloning and expression of phytase from aspergillus
Method of mapping restriction sites in polynucleotides
Enzyme inhibitors
Exhaust gas recirculation system
Process for thin film formation by sputtering